Lee, M., Cho, H. J., Hong, J. Y., Lee, J., Park, S. H., Park, J. O., . . . Kim, S. T. (2020). Clinical and molecular distinctions in patients with refractory colon cancer who benefit from regorafenib treatment. Ther Adv Med Oncol.
Citación estilo ChicagoLee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Cita MLALee, Min-Sang, et al. "Clinical and Molecular Distinctions in Patients With Refractory Colon Cancer Who Benefit From Regorafenib Treatment." Ther Adv Med Oncol 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.